Gene · 2494
Papers1,984
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,984
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering the regulatory landscape of enhancer RNAs in health and disease. | Signal Transduct Target Ther | 2026 | 41605892 | PubTator, text mining | PubMed |
| Overexpression of the pioneer transcription factor Nr5a2 promotes the development of mouse somatic cell nuclear transfer embryos. | PLoS Biol | 2026 | 41576045 | PubTator, text mining | PubMed |
| The potential of deep learning on the discovery of new genes implicated in differences of sex development. | Comput Struct Biotechnol J | 2026 | 41550136 | PubTator, text mining | PubMed |
| Identification of key ferroptosis-related targets in colorectal cancer: A transcriptomics-driven study via machine learning and AUcell analysis of single-cell RNA-sequencing. | J Cancer | 2026 | 41438584 | PubTator, text mining | PubMed |
| NR5A2 promotes epithelial-to-mesenchymal transition in renal fibrosis by targeting MMP25 transcription. | Biochim Biophys Acta Mol Basis Dis | 2026 | 41297641 | PubTator, text mining | PubMed |
| Epigenetic regulation of NR5A2 influences colorectal cancer cell stemness via a stemness-related transcription factor NANOG. | Cell Commun Signal | 2025 | 41214698 | PubTator, text mining | PubMed |
| Association of IL32 Variant rs45499297 with Gingivitis and IL-32 Levels: A Cross-sectional Clinical-bioinformatics Study. | Recent Adv Inflamm Allergy Drug Discov | 2025 | 41121508 | PubTator, text mining | PubMed |
| NR5A2 (located on chromosome 1q32) inhibits ferroptosis and promotes drug resistance by regulating phospholipid remodeling in multiple myeloma. | Int J Biol Sci | 2025 | 41079922 | PubTator, text mining | PubMed |
| Global understanding via local extraction for data clustering and visualization. | Patterns (N Y) | 2025 | 41040960 | PubTator, text mining | PubMed |
| Nitroxoline mitigates hepatic steatosis by enhancing cholesterol efflux and promoting bile acid synthesis through LRH-1 signaling. | Lipids Health Dis | 2025 | 41023714 | PubTator, text mining | PubMed |
| Promising Cancer Vaccine for Glioblastoma Therapy: A Focus on mRNA Vaccine. | Cancer Med | 2025 | 40948290 | PubTator, text mining | PubMed |
| Correction: of HSD3B1 upregulation via LRH1 sustains estrogen receptor signaling and promotes endocrine resistance in breast cancer. | J Biol Chem | 2025 | 40907246 | PubTator, text mining | PubMed |
| Parents' Perspectives on Participation Among Gifted and Typically Developing Children: A Pilot Study. | Children (Basel) | 2025 | 40868511 | PubTator, text mining | PubMed |
| Aberrant DNA methylation and overexpression of NR0B1 are prognostic biomarkers in KEAP1-mutant lung adenocarcinomas. | Discov Oncol | 2025 | 40864301 | PubTator, text mining | PubMed |
| Defining the cell and molecular origins of the primate ovarian reserve. | Nat Commun | 2025 | 40858568 | PubTator, text mining | PubMed |
| Treatment of Inborn Errors by Product Replacement: The Example of Inborn Errors of Bile Acid Synthesis. | J Inherit Metab Dis | 2025 | 40847535 | PubTator, text mining | PubMed |
| Effect of rubusoside, a natural sucrose substitute, on the metabolism of Scardovia wiggsiae: a novel potential cariogenic pathogen. | BMC Biol | 2025 | 40846930 | PubTator, text mining | PubMed |
| Many-objective optimization scheduling of cascade reservoirs in small watersheds based on an evolutionary multitasking framework. | Sci Rep | 2025 | 40596305 | PubTator, text mining | PubMed |
| [MLE (DHX9) Helicase Regulates the Expression of Constitutive and Inducible Isoforms of the Conserved Nuclear Receptor FTZ-F1 (NR5A3)]. | Mol Biol (Mosk) | 2025 | 40558038 | PubTator, text mining | PubMed |
| HSD3B1 upregulation via LRH1 sustains estrogen receptor signaling and promotes endocrine resistance in breast cancer. | J Biol Chem | 2025 | 40544998 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2494/papers?page=2